Norocaine Solution for Injection

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Lignocaine hydrochloride; Adrenaline acid tartrate

Available from:

Norbrook Laboratories Limited

ATC code:

QN01BB52

INN (International Name):

Lignocaine hydrochloride; Adrenaline acid tartrate

Dosage:

percent volume/volume

Pharmaceutical form:

Solution for injection

Prescription type:

VPO: Veterinary Practitioner Only as defined in relevant national legislation

Therapeutic group:

Horses

Therapeutic area:

lidocaine, combinations

Therapeutic indications:

Neurological Preparations

Authorization status:

Authorised

Authorization date:

1990-10-01

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Norocaine Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A clear colourless solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For infiltration anaesthesia (local or field block) and regional
anaesthesia.
4.3 CONTRAINDICATIONS
Do not administer by intravenous injection.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each ml contains:
Active Substances
Lidocaine (Lignocaine) Hydrochloride
20.00
mg
Epinephrine (Adrenaline as Adrenaline Acid Tartrate) 0.0125 mg
Excipients
Chlorocresol (preservative)
1.00
mg
Sodium metabisulphite (as an antioxidant)
1.00
mg
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_4_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_1_
_C_
_R_
_N_
_ _
_7_
_0_
_0_
_7_
_8_
_1_
_9_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The product is available in 100 ml and 500 ml pack sizes. The 500 ml
pack size should only be used in appropriate
situations. It should not be used for the administration of multiple
small dose volumes over an extended period of time.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
None.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Local infiltration of the product may delay wound healing.
4.7